TITLE

COMMENTARY: Review: Magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis

AUTHOR(S)
Weinshenker, Brian G.
PUB. DATE
September 2006
SOURCE
ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p51
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents comments of the author on a study conducted by researcher P. Whiting and colleagues on the effectiveness of the use of magnetic resonance imaging (MRI) in diagnosing multiple sclerosis. The reseachers did not address the accuracy of clinical diagnosis. They also did not consider the value of MRI in monitoring disease activity.
ACCESSION #
22493507

 

Related Articles

  • Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? Wattjes, Mike; Vennegoor, Anke; Mostert, Jop; Oosten, Bob; Barkhof, Frederik; Killestein, Joep // Journal of Neurology;Jun2014, Vol. 261 Issue 6, p1139 

    The diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients in an asymptomatic stage is crucial since it is associated with better clinical outcome measures. Current diagnostic criteria on PML diagnosis in asymptomatic patients require...

  • Critères diagnostiques cliniques de la sclérose en plaques : le rôle de l'imagerie par résonance magnétique. Bélair, Manon; Girard, Marc // Canadian Association of Radiologists Journal;Feb2004, Vol. 55 Issue 1, p29 

    The objective of this article is to summarize the diagnostic criteria recommended by the International Panel on the Diagnosis of Multiple Sclerosis in 2001. The recommendations of another working group, the Consortium of Multiple Sclerosis Centers Consensus Meeting, which met in Vancouver in...

  • When to Order Neuro-imaging. Winterkom, Jacquiline M. S. // Review of Ophthalmology;Aug2001, Vol. 8 Issue 8, p64 

    Examines the procedures in eye neuro-imaging test. Localization of lesions; Consideration of visual loss; Diagnosis of multiple sclerosis. INSET: New Techniques in Neuro-imaging..

  • Differential diagnosis in multiple sclerosis. Gasperini, C. // Neurological Sciences;Nov2001 Supplement 2, Vol. 22, pS93 

    Multiple sclerosis can usually be diagnosed from a patient's history, clinical examination, cerebrospinal fluid (CSF) analysis, and observations from magnetic resonance imaging (MRI). However, sometimes, the classic clinical criteria, even when supported by MRI findings or by abnormalities of...

  • Differential diagnosis of posterior fossa multiple sclerosis lesions � neuroradiological aspects. Falini, A.; Kesavadas, C.; Pontesilli, S.; Rovaris, M.; Scotti, G. // Neurological Sciences;Nov2001 Supplement 2, Vol. 22, pS79 

    Various infratentorial pathological conditions can mimic multiple sclerosis (MS) both clinically and radiologically. We review the inflammatory, vascular, neoplastic and metabolic conditions which show features similar to those of MS on magnetic resonance imaging (MRI). Beh�t's disease,...

  • Dr. Paty and the news from MRI's about MS. King, Martha // Inside MS;Summer95, Vol. 13 Issue 2, p14 

    Reports on the significance of Donald Paty's studies on magnetic resonance imaging (MRI) and multiple sclerosis (MS). Establishment of procedures for obtaining a series of images of the same individual over time; FDA approval of interferon beta-1b; Advantages over conventional neurological...

  • MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Barkhof, F. // Multiple Sclerosis (13524585);Aug99, Vol. 5 Issue 4, p283 

    Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR progression occurs frequently, explaining why MR is now used to monitor treatment, even without measurable consequences, of new MR lesions to the patient at this moment. In the light of this...

  • Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques. Filippi, M.; Tortorella, C.; Bozzali, M. // Multiple Sclerosis (13524585);Aug99, Vol. 5 Issue 4, p273 

    Several magnetic resonance (MR) techniques have proved to be sensitive enough to detect the subtle pathological changes that post-mortem studies showed to occur in the normal-appearing white matter (NAWM) from patients with multiple sclerosis (MS). Although these abnormalities can be detected in...

  • Modelling new enhancing MRI lesion counts in multiple sclerosis. Sormani, M.P.; Bruzzi, P.; Rovaris, M.; Barkhof, F.; Comi, G.; Miller, D.H.; Cutter, G.R.; Filippi, M. // Multiple Sclerosis (13524585);Oct2001, Vol. 7 Issue 5, p298 

    Magnetic resonance imaging (MRI) has been established as the most relevant paraclinical tool for diagnosing and monitoring multiple sclerosis (MS). In this context, counting the number of new enhancing lesions on monthly MRI scans is widely used as a surrogate marker of MS activity when...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics